Clinical Trials Browser

Phase 3 × Tuberous Sclerosis × Everolimus × Clear all

NCT02962414 2026-04-02

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Phase 3 Active not recruiting

206 enrolled

Seizures, Tuberous Sclerosis

NCT00790400 2017-02-17

EXIST-2

Phase 3 Completed

118 enrolled 15 charts

CNS

Tuberous Sclerosis 2, Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Seizures, Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT00789828 2016-02-03

EXIST-1

Phase 3 Completed

117 enrolled 15 charts

CNS

Astrocytoma, Tuberous Sclerosis